RELAY THERAPEUTICS INC
NASDAQ: RLAY (Relay Therapeutics, Inc.)
最近更新时间: 18小时之前14.81
0.57 (4.00%)
| 前收盘价格 | 14.24 |
| 收盘价格 | 14.21 |
| 成交量 | 1,770,119 |
| 平均成交量 (3个月) | 3,707,147 |
| 市值 | 3,227,696,384 |
| 价格/销量 (P/S) | 241.55 |
| 股市价格/股市净资产 (P/B) | 5.02 |
| 52周波幅 |
| 营业利益率 (TTM) | -1,105.21% |
| 稀释每股收益 (EPS TTM) | -2.20 |
| 季度收入增长率 (YOY) | -23.30% |
| 总债务/股东权益 (D/E MRQ) | 6.54% |
| 流动比率 (MRQ) | 19.96 |
| 营业现金流 (OCF TTM) | -271.99 M |
| 杠杆自由现金流 (LFCF TTM) | -155.22 M |
| 资产报酬率 (ROA TTM) | -28.82% |
| 股东权益报酬率 (ROE TTM) | -45.46% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Relay Therapeutics, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 2.0 |
| 内部交易活动 | NA |
| 价格波动 | -4.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | -0.13 |
|
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971). |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 1.48% |
| 机构持股比例 | 105.68% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Nextech Invest, Ltd. | 31 Mar 2026 | 5,526,506 |
| Spruce Street Capital Lp | 31 Mar 2026 | 2,984,125 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合